MEDA Pharmaceuticals Ltd. is the UK affiliate of MEDA AB, a leading international speciality pharmaceutical company. Originally founded in Sweden, MEDA now has a presence in 42 countries, employing over 2500 people. MEDA UK was established in 2002 and currently has 48 widely used, branded pharmaceutical products in its portfolio, which continues to expand. MEDA UK is active in the medical fields of - asthma, cardiology, cannabinoid medicine, dermatology, gastroenterology, movement disorders, pain management, sexual health, women’s health and virology. MEDA’s Medical Department can provide medical liaison, medical information, product knowledge, product training and Investigator Initiated Study support to healthcare professionals for Meda’s product range and in particular Virology. JB2218 August 2009 |
 At Celgene we believe that a commitment to medical progress achieved through innovative science and life-enhancing new therapies must go hand in hand with a corresponding promise to ensure that patients who can benefit from our discoveries have the opportunity to do so. www.celgene.co.uk |
||
 Click here to download SmPC  Click here to download  www.mds-foundation.org |
 Click here to download SmPC  Click here to download  http://www.myeloma.org.uk |
 Adverse events should be reported. Reporting forms and information can be found at www.yellowcard.gov.uk. Adverse events should also be reported to Celgene Drug Safety (Tel: 0808 238 9908; Fax: 0844 801 0468). Medical Information To contact Celgene in the UK for medical information and product supply enquiries, please telephone or e-mail the medical information department using the contact details below. Tel: +44 (0) 844 801 0045 Fax: +44 (0) 844 801 0046 medinfo.uk.ire@celgene.com |
| Sponsors | ||||||
|
EBMT(UK)NAP would like to acknowledge the support from the following companies for 2010. Please click on a logo to learn more about the company.
Senior Patron Sponsors:
Gold Sponsors:
Silver Sponsors:
|
